Cydan Announces The Promotion Of Dione Kobayashi, Ph.D., To Vice President, Preclinical Translation

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Cydan Development, Inc., an orphan drug accelerator dedicated to creating therapies that change the lives of patients living with rare diseases, today announced the promotion of Dione Kobayashi, Ph.D., to Vice President, Preclinical Translation effective Nov. 1. Dr. Kobayashi is an accomplished executive scientist with a deep knowledge of and experience in drug development activities for rare diseases, including drug screening, biomarker development and regulatory strategy.

Help employers find you! Check out all the jobs and post your resume.